289 related articles for article (PubMed ID: 4025364)
1. Aminoglycoside resistance in gram-negative bacilli during increased amikacin use. Comparison of experience in 14 United States hospitals with experience in the Minneapolis Veterans Administration Medical Center.
Gerding DN; Larson TA
Am J Med; 1985 Jul; 79(1A):1-7. PubMed ID: 4025364
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
Saavedra S; Vera D; Ramírez-Ronda CH
Am J Med; 1986 Jun; 80(6B):65-70. PubMed ID: 3014877
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of aminoglycoside resistance. European data.
Van Landuyt HW; Boelaert J; Glibert B; Gordts B; Verbruggen AM
Am J Med; 1986 Jun; 80(6B):76-81. PubMed ID: 3089007
[TBL] [Abstract][Full Text] [Related]
4. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital.
Gerding DN; Larson TA; Hughes RA; Weiler M; Shanholtzer C; Peterson LR
Antimicrob Agents Chemother; 1991 Jul; 35(7):1284-90. PubMed ID: 1929283
[TBL] [Abstract][Full Text] [Related]
5. Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin.
Ruiz-Palacios GM; Ponce de Leon S; Sifuentes J; Ponce de Leon S; Calva JJ; Huazano F; Ontiveros C; Ojeda F; Bobadilla M
Am J Med; 1986 Jun; 80(6B):71-5. PubMed ID: 3089006
[TBL] [Abstract][Full Text] [Related]
6. Resistance surveillance programs and the incidence of gram-negative bacillary resistance to amikacin from 1967 to 1985.
Gerding DN; Larson TA
Am J Med; 1986 Jun; 80(6B):22-8. PubMed ID: 3089003
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of the susceptibility patterns of gram-negative organisms isolated in cancer centres with aminoglycoside usage.
Muscato JJ; Wilbur DW; Stout JJ; Fahrlender RA
J Antimicrob Chemother; 1991 May; 27 Suppl C():1-7. PubMed ID: 1906860
[TBL] [Abstract][Full Text] [Related]
8. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
Drasar FA; Farrell W; Maskell J; Williams JD
Br Med J; 1976 Nov; 2(6047):1284-7. PubMed ID: 1000196
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
Watanakunakorn C; Kauffman CA
Infection; 1978; 6(3):111-5. PubMed ID: 98451
[TBL] [Abstract][Full Text] [Related]
10. Clinical and microbiologic consequences of amikacin use during a 42-month period.
Berk SL; Alvarez S; Ortega G; Verghese A; Holtsclaw-Berk SA
Arch Intern Med; 1986 Mar; 146(3):538-41. PubMed ID: 3954526
[TBL] [Abstract][Full Text] [Related]
11. In vitro aminoglycoside resistance of gram-negative bacilli and staphylococci isolated from blood in Sweden 1980-1984.
Bengtsson S; Bernander S; Brorson JE; Dornbusch K; Forsgren A; Hallander H; Henning C; Holm S; Malmborg AS; Nilsson L
Scand J Infect Dis; 1986; 18(3):257-63. PubMed ID: 3738436
[TBL] [Abstract][Full Text] [Related]
12. Treatment of pediatric infections with amikacin as first-line aminoglycoside.
Shulman ST; Yogev R
Am J Med; 1985 Jul; 79(1A):43-50. PubMed ID: 4025367
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
[TBL] [Abstract][Full Text] [Related]
14. Resistance to aminoglycoside antibiotics of gram-negative bacilli isolated in Canadian hospitals.
Duncan IB; Cheung EY; Haldane EV; Jackson FL; McNaughton RD; Morisset RA; Noble MA; Rennie RP; Ronald AR; Smith JA
Can Med Assoc J; 1981 May; 124(9):1165-7. PubMed ID: 7237336
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic resistance patterns during aminoglycoside restriction.
Young EJ; Sewell CM; Koza MA; Clarridge JE
Am J Med Sci; 1985 Dec; 290(6):223-7. PubMed ID: 3936358
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
Drugeon HB; Courtieu AL
Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
Knothe H
J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
[TBL] [Abstract][Full Text] [Related]
18. Suceptibility of aminoglycoside-resistant gram-negative bacilli to amikacin: delineation of individual resistance patterns.
Acar JF; Witchitz JL; Goldstein F; Talbot JN; Le Goffic F
J Infect Dis; 1976 Nov; 134 SUPPL():S280-5. PubMed ID: 825587
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the resistance mechanisms of gentamicin-resistant Gram-negative bacilli and their susceptibility to tobramycin, netilmicin and amikacin.
Maes P
J Antimicrob Chemother; 1985 Mar; 15(3):283-9. PubMed ID: 3997704
[TBL] [Abstract][Full Text] [Related]
20. [Antibacterial activity of amikacin towards gentamicin-resistant, Gram-negative bacilli].
Nicoletti G; Russo G; Toscano MA; Gismondo MR
Boll Ist Sieroter Milan; 1979 Jan; 57(6):713-7. PubMed ID: 121911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
